First Murder Conviction for Fentanyl Dealer Delivered in California
Medically reviewed by Drugs.com.
By Physician’s Briefing Staff HealthDay Reporter
TUESDAY, July 11, 2023 -- A fentanyl dealer has been found guilty of second-degree murder in what authorities believe is the first-ever murder conviction for dealing the dangerous drug.
The conviction happened in Placer County, California, in a case involving the fatal overdose last summer of a 15-year-old girl in Roseville, about 20 miles northeast of Sacramento, ABC7 News reported.
"This conviction could be a watershed moment in the war on fentanyl," said Steven Clark, legal analyst and former Santa Clara County District Attorney. "The fact that there was a conviction sends a message to the people dealing fentanyl," he said, noting that the key to these cases is proving the dealer knew they were selling deadly fentanyl.
The person convicted is a 21-year-old, ABC7 News reported.
"Fentanyl is everywhere and it's deadly," Placer County District Attorney Morgan Gire said recently. "If they choose to continue their behavior and sell and kill, the consequences will increase and they will be severe."
He predicted that more of these cases will be prosecuted, because traditional drug laws have not stopped people from selling fentanyl and it has become a national health crisis.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
![](/img/logo/vendor/healthday-logo.png)
© 2024 HealthDay. All rights reserved.
Posted July 2023
Read this next
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
Self-Administered Gerocognitive Exam Improves Detection of Cognitive Issues in Primary Care
TUESDAY, July 2, 2024 -- A self-administered gerocognitive examination (SAGE) is easily incorporated into primary care provider (PCP) visits, and its use significantly increases...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.